{"id":"https://openalex.org/W1542019334","doi":"https://doi.org/10.1163/15693910260698258","title":"Differences in rotational asymmetry in rats caused by single intranigral injections of 6-hydroxydopamine, 1-methyl-4-phenylpyridinium ion and rotenone","display_name":"Differences in rotational asymmetry in rats caused by single intranigral injections of 6-hydroxydopamine, 1-methyl-4-phenylpyridinium ion and rotenone","publication_year":2002,"publication_date":"2002-08-01","ids":{"openalex":"https://openalex.org/W1542019334","doi":"https://doi.org/10.1163/15693910260698258","mag":"1542019334"},"language":"en","primary_location":{"id":"doi:10.1163/15693910260698258","doi":"https://doi.org/10.1163/15693910260698258","is_oa":false,"landing_page_url":"https://doi.org/10.1163/15693910260698258","pdf_url":null,"source":{"id":"https://openalex.org/S132057664","display_name":"Biogenic Amines","issn_l":"0168-8561","issn":["0168-8561","1569-3910"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310320561","host_organization_name":"Brill","host_organization_lineage":["https://openalex.org/P4310320561","https://openalex.org/P4310313990"],"host_organization_lineage_names":["Brill","De Gruyter"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biogenic Amines","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061628159","display_name":"Masatoshi Inden","orcid":"https://orcid.org/0000-0002-7480-4920","observed_orcids":["https://orcid.org/0000-0002-7480-4920"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103184289","display_name":"Kaneyasu Nishimura","orcid":"https://orcid.org/0000-0002-5582-3341","observed_orcids":["https://orcid.org/0000-0002-5582-3341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nishimura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106037838","display_name":"Sawada Sawada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sawada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043617430","display_name":"Tsuchiya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tsuchiya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110758210","display_name":"Kondo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kondo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110753349","display_name":"Taniguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taniguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109845097","display_name":"Kitamura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kitamura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032064265","display_name":"Kazuyuki Takata","orcid":"https://orcid.org/0000-0001-5332-1279","observed_orcids":["https://orcid.org/0000-0001-5332-1279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5096859949","display_name":"Shimohama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shimohama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8685,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.72251064,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"17","issue":"4","first_page":"281","last_page":"291"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/6-hydroxydopamine","display_name":"6-hydroxydopamine","score":0.968999981880188},{"id":"https://openalex.org/keywords/mpp","display_name":"MPP+","score":0.9629999995231628},{"id":"https://openalex.org/keywords/rotenone","display_name":"rotenone","score":0.9950000047683716},{"id":"https://openalex.org/keywords/dopaminergic-neurotoxin","display_name":"dopaminergic neurotoxin","score":0.9480000138282776},{"id":"https://openalex.org/keywords/rotational-asymmetry","display_name":"rotational asymmetry","score":0.7940000295639038},{"id":"https://openalex.org/keywords/apomorphine-induced-rotation","display_name":"apomorphine-induced rotation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/substantia-nigra","display_name":"substantia nigra","score":0.9020000100135803},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.9789999723434448},{"id":"https://openalex.org/keywords/dopaminergic-neuron-degeneration","display_name":"dopaminergic neuron loss","score":0.9490000009536743},{"id":"https://openalex.org/keywords/intranigral-injection","display_name":"intranigral injection","score":0.8140000104904175},{"id":"https://openalex.org/keywords/parkinson-s-disease-model","display_name":"Parkinson's disease model","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C2778389096","wikidata":"https://www.wikidata.org/wiki/Q412388","display_name":"Rotenone","level":3,"score":0.9084988832473755},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.8551157712936401},{"id":"https://openalex.org/C2911016594","wikidata":"https://www.wikidata.org/wiki/Q15946111","display_name":"Hydroxydopamine","level":4,"score":0.7489199042320251},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.7356692552566528},{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.7115979194641113},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.6568474173545837},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6557847857475281},{"id":"https://openalex.org/C2780358027","wikidata":"https://www.wikidata.org/wiki/Q407752","display_name":"Neurotoxin","level":2,"score":0.6441437602043152},{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.5491679310798645},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4334205090999603},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.41431209444999695},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.365072637796402},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29846739768981934},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16906088590621948},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13886326551437378},{"id":"https://openalex.org/C28859421","wikidata":"https://www.wikidata.org/wiki/Q39572","display_name":"Mitochondrion","level":2,"score":0.1324494183063507},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.11855638027191162},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1163/15693910260698258","doi":"https://doi.org/10.1163/15693910260698258","is_oa":false,"landing_page_url":"https://doi.org/10.1163/15693910260698258","pdf_url":null,"source":{"id":"https://openalex.org/S132057664","display_name":"Biogenic Amines","issn_l":"0168-8561","issn":["0168-8561","1569-3910"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310320561","host_organization_name":"Brill","host_organization_lineage":["https://openalex.org/P4310320561","https://openalex.org/P4310313990"],"host_organization_lineage_names":["Brill","De Gruyter"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biogenic Amines","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4237258445","https://openalex.org/W2029945109","https://openalex.org/W1997705292","https://openalex.org/W2071329247","https://openalex.org/W2357826896","https://openalex.org/W1974178481","https://openalex.org/W2011392058","https://openalex.org/W2040895626","https://openalex.org/W2057062992","https://openalex.org/W2391556011"],"abstract_inverted_index":{"Recently,":[0],"6-hydroxydopamine":[1],"(6-OHDA),":[2],"1-methyl-4-phenylpyridinium":[3],"ion":[4],"(MPP+)":[5],"and":[6,40,63,65,82,90],"rotenone":[7,41,91],"have":[8],"been":[9],"shown":[10],"to":[11],"be":[12],"dopaminergic":[13,56,96,118],"neurotoxins.":[14],"However,":[15],"their":[16],"neurotoxicities":[17,36],"in":[18,21,34,58,76,98,120,122],"rat":[19],"brains":[20],"vivo":[22,35],"are":[23],"not":[24,84],"fully":[25],"understood.":[26],"In":[27,70],"the":[28,33,52,60,77,99],"present":[29],"study,":[30],"we":[31],"compared":[32],"of":[37,49,55,95,111,117],"6-OHDA,":[38],"MPP+":[39,89],"using":[42],"a":[43,93],"single":[44],"intranigral":[45,109],"injection.":[46],"The":[47],"injection":[48],"6-OHDA":[50],"caused":[51,92],"greatest":[53],"loss":[54,94],"neurons":[57,97],"both":[59],"substantia":[61,100],"nigra":[62],"striatum,":[64],"apomorphine":[66],"induced":[67],"contralateral":[68],"rotation.":[69],"contrast,":[71],"apomorphine-induced":[72],"rotational":[73],"behavior":[74],"was":[75,83],"ipsilateral":[78],"direction":[79],"with":[80,86],"MPP+,":[81],"observed":[85],"rotenone.":[87],"Although":[88],"nigra,":[101],"striatal":[102],"neurodegeneration":[103],"varied.":[104],"These":[105],"results":[106],"suggest":[107],"that":[108],"injections":[110],"these":[112],"neurotoxins":[113],"produce":[114],"different":[115],"degrees":[116],"neurotoxicity":[119],"rats":[121],"vivo.":[123]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}